- Home
- AZ vs AXDX Comparison
AZ vs AXDX Comparison
Compare AZ & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZ
- AXDX
- Stock Information
- Founded
- AZ 2018
- AXDX 1982
- Country
- AZ Canada
- AXDX United States
- Employees
- AZ N/A
- AXDX N/A
- Industry
- AZ Industrial Machinery/Components
- AXDX Biotechnology: Laboratory Analytical Instruments
- Sector
- AZ Industrials
- AXDX Industrials
- Exchange
- AZ Nasdaq
- AXDX Nasdaq
- Market Cap
- AZ 36.4M
- AXDX 41.8M
- IPO Year
- AZ N/A
- AXDX 1996
- Fundamental
- Price
- AZ $6.94
- AXDX $1.64
- Analyst Decision
- AZ
- AXDX Hold
- Analyst Count
- AZ 0
- AXDX 1
- Target Price
- AZ N/A
- AXDX $1.00
- AVG Volume (30 Days)
- AZ 137.2K
- AXDX 56.0K
- Earning Date
- AZ 11-13-2024
- AXDX 11-07-2024
- Dividend Yield
- AZ N/A
- AXDX N/A
- EPS Growth
- AZ N/A
- AXDX N/A
- EPS
- AZ N/A
- AXDX N/A
- Revenue
- AZ $6,628,000.00
- AXDX $11,909,000.00
- Revenue This Year
- AZ $30.95
- AXDX $1.42
- Revenue Next Year
- AZ $646,436.00
- AXDX $4.09
- P/E Ratio
- AZ N/A
- AXDX N/A
- Revenue Growth
- AZ N/A
- AXDX N/A
- 52 Week Low
- AZ $0.85
- AXDX $0.73
- 52 Week High
- AZ $7.00
- AXDX $5.23
- Technical
- Relative Strength Index (RSI)
- AZ 72.93
- AXDX 36.72
- Support Level
- AZ $6.07
- AXDX $1.77
- Resistance Level
- AZ $6.69
- AXDX $2.04
- Average True Range (ATR)
- AZ 0.57
- AXDX 0.12
- MACD
- AZ -0.02
- AXDX -0.04
- Stochastic Oscillator
- AZ 97.22
- AXDX 9.09
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.